The Mthfr Ct Polymorphism Confers a High Risk for Stroke in Both Homozygous and Heterozygous T Allele Carriers with Type 2 Diabetes.
From: Department of Endocrinology and Nutrition, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium.
Diabetic medicine : a journal of the British Diabetic Association
- Publish Date: May 2006
- ISSN: 0742-3071
- Volume: 23
- Issue: 5
- Pages: 529-36
- Medium: Print
- Language: English
- Citation (JAMA): Hermans M P, Gala J-L, Buysschaert M, et al. The Mthfr Ct Polymorphism Confers a High Risk for Stroke in Both Homozygous and Heterozygous T Allele Carriers with Type 2 Diabetes.. Diabet. Med. May 2006;23:529-36
Abstract
OBJECTIVE: Individuals with Type 2 diabetes are at increased risk of stroke. Plasma homocysteine (tHcy) is an independent risk factor for cardiovascular (CV) disease. The methylene-tetrahydrofolate reductase (MTHFR) gene polymorphism (thermolabile variant C(677)T) is associated with CV risk, partly as a result of increased Hcy, especially in homozygous subjects. AIM: To relate the occurrence of the MTHFR polymorphism with stroke prevalence by examining allelic frequency and genotype distribution in 165 subjects with Type 2 diabetes studied for the presence of thermolabile C(677)T MTHFR mutation. RESULTS: Mean age was 67.7 years, and tHcy 18.2 micromol/l. T allele frequency was 38.5%. MTHFR genotypes were: normal (CC) 40%; heterozygous (CT) 43%; homozygous (TT) 17%. Serum levels of folic acid and B12 vitamin were within normal limits. Stroke prevalence was 14%. Sixty-four per cent of stroke-free subjects had the normal C allele vs. 46% in stroke subjects. The frequencies of genotypes (CC-CT-TT) were (%): 44-41-15 in stroke-free vs. 17-57-26 in stroke patients. Coronary (CAD) and peripheral artery disease (PAD) were common in all groups, with no differences according to genotypes. Stroke prevalence was markedly higher in genotypes CT and TT (18 and 21%) compared with CC (6%). Mean tHcy levels were higher in TT subjects. CONCLUSION: The allelic frequency of C(677)T MTHFR mutation in Type 2 diabetes subjects with stroke is markedly different from that of subjects without stroke. Genotypic characteristics suggest that C(677)T MTHFR mutation confers a higher risk for stroke to both homozygous and heterozygous T allele carriers that cannot be ascribed solely to raised tHcy and/or lower folate status in CT subjects, nor to phenotypic expression of conventional risk factors for stroke. The impact of the MTHFR polymorphism on stroke may result from T allele-linked deleterious effects, or C allele-linked protection. Confirmatory studies are warranted, as this cohort was not randomly selected, and a type 1 error cannot be ruled out.
Mesh Headings (Keywords): Aged, Cohort Studies, Coronary Artery Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Folic Acid, Gene Frequency, Heterozygote, Homozygote, Humans, Male, Methylenetetrahydrofolate Reductase (NADPH2), Mutation, Peripheral Vascular Diseases, Polymorphism, Genetic, Risk Factors, Stroke, Vitamin B 12
Check for Full Text / PubMed Unique Identifier (PMID): 16681562
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.